UC Irvine Researchers Advance Targeted Chemotherapy to Protect Healthy Cells
A New Experimental Prodrug Developed at UC Irvine Is Designed to Activate Only When It Encounters Elevated Protein-Destroying Activity Inside Cancer Cells.

Search the full Irvine Source archive, browse by topic, or explore what's trending.
Share this #targeted-chemotherapy feed
A New Experimental Prodrug Developed at UC Irvine Is Designed to Activate Only When It Encounters Elevated Protein-Destroying Activity Inside Cancer Cells.

A New Strategy Uses Internal Cellular Machinery to Activate Cancer Drugs More Precisely, Potentially Reducing Harm to Healthy Tissue.
